6/15/16 17:50 | 6/13/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -5 | 1.03 | 1 | -5 | -2 | 203 | M | -68 | -61 | -8 | 30 | 6 | 11 | -10 | 7 | -3 | -3 | -9 | -49 | -50 | |
3/16/16 18:26 | 3/15/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -10 | 0.8300 | 0 | -12 | -6 | 194 | D | -93 | -64 | -67 | -29 | 34 | 32 | 11 | 6 | -4 | -6 | 1 | 31 | -36 | -38 |
6/16/15 15:06 | 6/12/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -12 | 2.69 | 2 | -5 | -4 | 112 | D | -72 | -18 | 18 | 19 | 38 | 28 | 10 | -1 | -3 | 1 | -10 | -9 | -58 | -61 |
5/21/15 18:28 | 5/20/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -14 | 1.88 | 0 | -8 | -7 | 107 | D | -82 | -50 | -14 | -16 | -18 | -6 | 6 | -3 | -2 | 14 | 45 | 48 | 24 | -52 |
8/14/14 18:01 | 8/13/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -58 | 3.17 | 0 | -18 | -18 | 84 | D | -77 | -65 | -72 | -17 | -9 | 3 | 12 | 5 | 0 | -3 | -5 | -35 | -36 | -4 |
3/18/14 19:22 | 3/17/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -57 | 12.25 | 4 | -5 | -4 | 122 | D | -21 | 1 | 35 | 53 | 16 | 9 | 0 | -5 | -1 | -1 | -23 | -76 | -80 | -86 |
10/7/13 15:21 | 8/19/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.a | -27 | 8.68 | 1 | -3 | -5 | 60 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
10/7/13 15:19 | 3/12/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.a | -25 | 11.90 | 1 | -2 | -4 | 57 | D | -2 | -38 | -14 | -8 | -3 | -3 | -1 | -2 | -1 | -1 | -22 | 3 | 10 | -73 |
1/6/11 19:05 | 1/4/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -165 | 16.52 | 1 | -10 | -13 | 65 | M | 286 | -21 | 31 | 19 | 5 | 7 | 7 | 2 | -1 | 0 | -7 | -10 | 0 | -34 |
12/3/10 16:52 | 12/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -80 | 16.02 | 1 | -5 | -8 | 57 | M | 611 | -52 | 12 | 23 | -8 | 0 | -4 | -1 | 0 | 0 | 5 | -3 | 13 | -28 |
11/17/10 16:19 | 11/15/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -80 | 15.99 | 2 | -5 | -9 | 52 | M | 563 | -49 | -7 | 15 | 11 | -5 | 0 | -1 | 3 | 2 | 0 | -1 | -3 | -23 |
11/2/10 18:58 | 11/1/10 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | S.d | -77 | 15.45 | 3 | -5 | -10 | 47 | D | 513 | -45 | -27 | 6 | 30 | -14 | -9 | -5 | -1 | -3 | -2 | -3 | -5 | -30 |